Valuation: EXACT Therapeutics

Market Cap 4.37Cr 46.24L 39.94L 37.53L 34.13L 64.17L 44Cr 65.23L 4.4Cr 1.72Cr 22Cr 1.74Cr 1.7Cr 74Cr P/E 2024
-2.49x
P/E 2025 -1x
Enterprise Value 1.97Cr 20.91L 18.06L 16.97L 15.44L 29.02L 20Cr 29.5L 1.99Cr 77.75L 10Cr 78.51L 76.81L 33Cr EV / Sales 2024
-
EV / Sales 2025 1,07,44,37,000x
Free-Float
30.97%
Yield 2024 *
-
Yield 2025 -
1 day-1.43%
1 week-8.00%
Current month-1.43%
1 month-4.83%
3 months-46.51%
6 months-63.68%
Current year-50.00%
1 week 0.69
Extreme 0.69
0.8
1 month 0.64
Extreme 0.635
0.8
Current year 0.58
Extreme 0.58
2.7
1 year 0.58
Extreme 0.58
2.98
3 years 0.58
Extreme 0.58
20
5 years 0.58
Extreme 0.58
23
10 years 0.58
Extreme 0.58
53.59
Manager TitleAgeSince
Chief Executive Officer 66 06/06/2022
Chief Operating Officer - 01/01/2012
Director of Finance/CFO - 01/10/2022
Director TitleAgeSince
Chairman 55 22/06/2018
Chairman - 08/06/2022
Director/Board Member 59 -
Date Insider Type Main position Quantity % Market Cap.
04/01/23 Buy

Chairman

2,500 0.0083%
04/01/23 Buy

Founder

2,500 0.0083%
04/01/23 Buy

Chief Financial Officer

2,500 0.0083%
Change 5-day change 1-year change 3-year change Capi.($)
-1.43%-8.00%-76.37%-94.25% 46.24L
-1.78%-1.68%+1.48%+17.26% 4.84TCr
+0.85%-0.70%+460.88%+581.30% 4.37TCr
-2.40%-0.23%+8.13%+80.67% 3.95TCr
-2.01%-0.85%+23.85%+9.97% 3.9TCr
-0.50%+0.85%+20.60%+58.18% 3.26TCr
+0.38%-3.23% - - 1.63TCr
-0.59%-2.06%+26.35%+126.36% 1.61TCr
+0.49%+0.92%+4.11%+26.37% 1.42TCr
-0.43%+4.70%+78.74%+38.66% 1.34TCr
Average -0.74%-0.10%+60.86%+93.84% 2.63TCr
Weighted average by Cap. -0.91%+0.59%+95.83%+140.26%

Financials

2024 2025
Net sales - 0.06 0.01 0.01 0.01 0 0.01 0.6 0.01 0.06 0.02 0.3 0.02 0.02 0.99
Net income -5.23Cr -55.44L -47.88L -44.99L -40.92L -76.93L -53Cr -78.2L -5.27Cr -2.06Cr -27Cr -2.08Cr -2.04Cr -88Cr -8.7Cr -92.13L -79.57L -74.77L -68L -1.28Cr -88Cr -1.3Cr -8.76Cr -3.43Cr -44Cr -3.46Cr -3.38Cr -146.6Cr
Net Debt -9.89Cr -1.05Cr -90.48L -85.02L -77.32L -1.45Cr -100.17Cr -1.48Cr -9.96Cr -3.9Cr -50Cr -3.93Cr -3.85Cr -166.7Cr -2.39Cr -25.33L -21.88L -20.56L -18.7L -35.15L -24Cr -35.73L -2.41Cr -94.18L -12Cr -95.1L -93.04L -40Cr
Logo EXACT Therapeutics
Exact Therapeutics AS is a Norway-based clinical-stage biopharmaceutical company, which develops ultrasound-mediated technology platform for targeted therapeutic enhancement Acoustic Cluster Therapy (ACT). ACT sonoporation is an approach to ultrasound-mediated, targeted drug enhancement with the potential to significantly amplify the clinical utility of a wide range of therapeutic agents across a multitude of indications including within cancer (chemotherapy, immunotherapy), infectious diseases, and neurological conditions. The Company's purpose is to extend and enrich patient lives through targeted therapeutic enhancement. It is done through harnessing the power of ultrasound in combination with ACT formulation.
Employees
11
Date Price Change Volume
14/26/14 NOK 0.6900 -1.43% 16,673
13/26/13 NOK 0.7000 0.00% 28,906
12/26/12 NOK 0.7000 0.00% 0
11/26/11 NOK 0.7000 -6.67% 2,000
10/26/10 NOK 0.7500 0.00% 0
  1. Stock Market
  2. Stocks
  3. EXTX Stock